InvestorsHub Logo
Followers 829
Posts 119621
Boards Moderated 14
Alias Born 09/05/2002

Re: jbog post# 17985

Sunday, 12/03/2017 5:05:38 PM

Sunday, December 03, 2017 5:05:38 PM

Post# of 20689
The Orencia and Necuparanib disclosures didn't attain the threshold of materiality that would mandate a quick 8-K filing, so we can't really grade MNTA's disclosure policy based on those events.

The McPherson situation, OTOH, would seem to warrant an 8-K filing, and I don't know why it hasn't happened yet.

In any case, the damage to MNTA's share price has already been done, so an 8-K related to McPherson (if there is one) probably won't have more than a fleeting effect, IMO.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”